BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified

Blood Cancer J. 2021 Sep 16;11(9):153. doi: 10.1038/s41408-021-00549-6.

¹ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pstrati@mdanderson.org.
⁶ Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pstrati@mdanderson.org.

^# Contributed equally.

No abstract available

Publication types